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CD4þ T-cell survival in the GI tract requires
dectin-1 during fungal infection
RA Drummond1,6, IM Dambuza1, S Vautier1,6, JA Taylor1, DM Reid1, CC Bain2,
DM Underhill3, D Masopust4, DH Kaplan5 and GD Brown1
Dectin-1 is an innate antifungal C-type lectin receptor necessary for protective antifungal immunity. We recently
discovered that Dectin-1 is involved in controlling fungal infections of the gastrointestinal (GI) tract, but how this C-type
lectin receptor mediates these activities is unknown. Here, we show that Dectin-1 is essential for driving fungal-specific
CD4þ T-cell responses in the GI tract. Loss of Dectin-1 resulted in abrogated dendritic cell responses in themesenteric
lymph nodes (mLNs) and defective T-cell co-stimulation, causing substantial increases in CD4þ T-cell apoptosis and
reductions in the cellularity of GI-associated lymphoid tissues. CD8þ T-cell responses were unaffected by Dectin-1
deficiency. These functions of Dectin-1 have significant implications for our understanding of intestinal immunity and
susceptibility to fungal infections.
INTRODUCTION
Innate recognition of fungi is primarilymediated by a large class
of myeloid-expressed pattern recognition receptors, termed the
C-type lectin receptors.1 Dectin-1 (gene symbol Clec7a) is the
prototypical member of this family and is an essential
component of the protective immune response to numerous
fungal pathogens including Candida albicans,2 Pneumocystis
carinii,3 and Aspergillus fumigatus.4 Dectin-1 binds exposed
b-glucans in fungal cell walls and initiates complex intracellular
signaling pathways through Syk kinase and CARD9 leading to
phagocytosis of fungi, the respiratory burst, and pro-inflam-
matory cytokine production.1 Dectin-1 has also been shown to
influence the development of adaptive antifungal immunity by
driving Th17 polarization.5 More recently, C-type lectin
receptors such as Dectin-2 (gene symbol Clec4n) have been
implicated in anti-Candida immunity, in part through
collaborative interactions with Dectin-1 and other pattern
recognition receptors.6,7
Fungi are now recognized as important components of the
murine and human gastrointestinal (GI) microbiomes.8–10 In
humans, C. albicans is a common GI commensal and this
population is thought to serve as reservoir for systemic
infections following invasion of GI tissues under conditions
of immunosuppression.11–13 In addition to protecting against
systemic fungal disease, we have shown that Dectin-1 has a
crucial role in protecting the GI tract during systemic
candidiasis and in inflammatory bowel disorders, although
the Dectin-1-dependent mechanisms operating in this tissue
are not understood.8,14 In murine models of colitis, where DSS
is used to disrupt the mucosal barrier, we found that
Dectin-1 / mice exhibited enhanced inflammation if exposed
toCandidaduring the induction of colitis. In linewith themurine
studies, we identified a single-nucleotide polymorphism in
human CLEC7A (rs2078178) that significantly associated with
ulcerative colitis.8 Moreover, we have found that Dectin-1 /
animals systemically infected with C. albicans have increased GI
fungal burdens and dysregulated cytokine production.14 These
data therefore suggest that Dectin-1 has a crucial role in
protecting the GI tract from fungal-mediated inflammation.
Our understanding of Dectin-1-dependent antifungal
immunity has concentrated largely on its innate functions
and we still know little about the influence of this receptor on
adaptive immunity during infection. The role of Dectin-1
and other C-type lectin receptors in driving these responses is
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likely to be important for GI tract homeostasis, as defects in
T-cell function within the human and mouse gut, particularly
Th17 polarization, is associated with inflammatory bowel
disease.15 We therefore examined the role of Dectin-1 in
controlling T-cell activation in the GI tract during fungal
infection.
RESULTS
Dectin-1 controls GI antigen-specific CD4þ T-cell
responses
We systemically infected wild-type (WT) and Clec7a /
(Dectin-1 KO) animals with C. albicans and found significant
increases in fungal burdens in the kidneys and small intestine of
Dectin-1 / mice (Figure 1a, b), as we had observed
previously.2,14 In addition to enhanced infection of the small
intestine, infected Dectin-1 KO mice had significantly higher
bile-acid levels in the small intestine (Figure 1c).14 Despite an
increase in the bile-acid-synthesizing enzymeCyp7a1 (ref. 16) in
the liver during infection, Dectin-1 KO mice displayed poor
upregulation of the intestinal negative feedback regulator, Fgf15
(ref. 17) (Figure 1d), suggesting that the increased bile acids
were the result of a defect in this negative feedback loop.
However, including the bile-acid-sequesterant cholestyramine18
in the diet lowered bile acids to WT levels but did not signifi-
cantly alter fungal burdens in the small intestine (Figure 1e).
This suggests that the altered bile-acid concentration within the
Dectin-1 KO mice is not responsible for the lack of control of
fungal infection in these tissues.
To characterize the role of Dectin-1 in antigen-specific T-cell
responses during infection, we made use of the OT.I/OT.II
T-cell transgenic system and a previously characterized strain
of C. albicans expressing ovalbumin (OVA) peptides
(Calb-Ag),19 as there are no T-cell receptor transgenic models
specific for C. albicans currently available. We adoptively
transferred CD4þ OT.II cells into WT and Dectin-1 /
animals and then 24 h later infected these mice with Calb-Ag.
Responding OT.II cells were subsequently analyzed in various
tissues by flow cytometry. We found a specific reduction in the
frequency and number of OT.II T-cells within the intestinal
draining mesenteric lymph nodes (mLN) and small intestine of
Dectin-1 / mice compared with WT animals (Figure 1f, g),
despite increased expression of gut-homing receptors CCR9
anda4b7 byCD4þ T-cells in themLN (Figure 1h). In contrast,
we found no reduction in the frequency of these cells in the
spleen (Figure 1f), kidney-draining (renal) lymph nodes
during infection, or in these tissues in naive animals
(Supplementary Figure 1a, b online).
Owing to the lack of OT.II T-cells in the infected Dectin-1
KO small intestine, we were unable to analyse any functional
parameters in this tissue and therefore concentrated our
analysis on the mLNs. OT.II responses were generally weak in
this LN when compared with the renal LNs and spleen at this
time point, which are likely to be related to the lower fungal
burdens found in the intestine (Figure 1b). Nevertheless, we
found that OT.II responses in the mLN were differentially
regulated in the Dectin-1 KOmice. Monitoring cell division by
carboxyfluorescein succinimidyl ester dilution, OT.II prolifera-
tion increased from day 3 to day 6 in theWTmLNs. In contrast,
the Dectin-1 KO mice did not show any increase in prolifera-
tion over this time period (Figure 1i and Supplementary
Figure S2). Similar to the defect in frequency, this reduction in
proliferation of antigen-specific CD4þ T-cells was only evident
in the GI tract, as no defects were detected in the spleen or renal
lymph nodes of Dectin-1 KO mice (Supplementary Figure
S1c, d). Interestingly, Dectin-1 deficiency did not reduce OT.II
cell activation, measured by CD69 upregulation, which was
enhanced overWT in both themLN and the spleen (Figure 1j).
Moreover, Dectin-1 was not required for T-cell polarization,
measured by master transcription factor expression, in any of
the sites analyzed (Figure 1k and Supplementary Figure S1c,
d). However, we did detect a non-significant reduction in
interleukin (IL)-17 production from mLN cells following
in vitro restimulation (Figure 1l), consistent with previous
reports showing a role for this receptor in driving Th17
responses.5
Dectin-1 is not required for antigen-specific CD8þ T-cell
responses in the GI tract
To explore the effect of Dectin-1 deficiency on CD8þ T-cell
responses during fungal infection, we adoptively transferred
CD8þ OT.I cells into WT and Dectin-1 / animals and then
24 h later infected these mice with Calb-Ag. Responding OT.I
cells were subsequently analyzed in various tissues by flow
cytometry. In contrast to the effect on CD4þ T-cells, Dectin-1
deficiency had no effect on the relative frequency of antigen-
specific CD8þ T-cells in the mLN (Figure 2a). Moreover,
unlike the CD4þ T-cell response, Dectin-1 deficiency did not
affect division (Figure 2b) or activation (Figure 2c) of OT.I
cells in any tissue analyzed. Thus, these data show that Dectin-1
controls fungal-specific CD4þ , but not CD8þ , T-cell
proliferation to the GI tract.
Dectin-2 does not control CD4þ T-cell function in the GI
tract
Like Dectin-1, Dectin-2 has been shown to have a non-
redundant role during systemic candidiasis in vivo,6 so we
assessed whether absence of this receptor would also affect
CD4þ T-cell responses during infection.We found significantly
enhanced fungal burdens in the small intestine at 72h post
infection in the Dectin-2 / mice compared with WT
(Figure 3a), similar to the Dectin-1 KO animals. However,
unlike the Dectin-1 KO animals, we did not find any reductions
in the frequency or proliferation of antigen-specific CD4þ
T-cells in the GI tract or mLN of the Dectin-2 / mice
(Figure 3b, c). Like the Dectin-1 / mice, CD69 expression by
antigen-specific CD4þ T-cells was significantly enhanced in the
Dectin-2 / mice (Figure 3d), suggesting that this pheno-
type may be related to the increased intestinal fungal burdens.
We also found a reduction in the expression of RORgt in the
mLN of the Dectin-2 / animals (Figure 3e), in line with
published findings that Dectin-2 is required for production of
Th17-polarizing cytokines by dendritic cell (DC)s;6 however, did
not detect any reduction in IL-17 production upon in vitro
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restimulation (Figure 3f). Taken together, these data demon-
strate that the loss of Dectin-2 does not alter fungal-specific
CD4þ T-cell immunity in the GI tract. Importantly, these
data also establish that high intestinal fungal burdens are not
responsible for the T-cell defect observed in the Dectin-1 /
mice.
LossofDectin-1doesnot confer globalCD4þ T-cell defects
Dectin-1 has been demonstrated to have endogenous T-cell
ligands20 and to be expressed in the corticomedullary junctions
of the thymus.21 Therefore, we next considered the possibility
that the loss of Dectin-1 was broadly affecting CD4þ T-cell
immunity. To examine this possibility, we analyzed OT.II
responses in Dectin-1 KOs immunised in the footpad with
purified OVA together with the Toll-like receptor 9 agonist
oligodeoxynucleotide. However, we did not find any reduction
in the frequency of antigen-specific OT.II cells (Figure 4a), or
their proliferation and activation in the draining LNs in these
animals (Figure 4b, c).
In the absence of a global defect, we next sought to determine
whether Dectin-1 was specifically required for T-cell function
in the GI tract. We first attempted oral administration of
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Figure 1 Dectin-1 is required for fungal-specific CD4þ T-cell responses in the GI tract. WT (filled bars/circles) and Dectin-1 / (clear bars/circles)
animals were systemically infected via the tail vein with 2 105 CFUC. albicans and analyzed at 72 h post infection for (a) kidney (WT n¼ 25, KO n¼25)
and (b) small intestine fungal burdens (WT n¼ 17, KO n¼ 21). (c) Bile-acid concentration in the small intestine of infected WT (n¼ 5) and Dectin-1 KO
(n¼ 6) mice. (d) The fold change (to naı¨ve controls) in genes regulating bile-acid synthesis (Cyp7a1) or in bile-acid-negative feedback (Fgf15) were
measured in 3 day infected livers and intestines (respectively) by quantitativePCR (n¼ 3). (e)WT (n¼ 10) andDectin-1KO (n¼ 9) animalsmaintained on
cholestyramine diets starting at 24 h pre-infection until 72 h post infection, when bile acids were measured as in (c), and intestine fungal burdens
determined. In other experiments, 3 106OT.II T-cells were transferred intoWT andDectin-1 / animals, and then infected via the tail vein with 2105
CFU Calb-Ag and analyzed at 72 h post infection. (f) Frequency of OT.II T-cells (CD4þVa2þCD45.1þ ) was assessed by flow cytometry in the spleen
(n¼ 12), mLNs (n¼ 12), and small intestine (n¼ 8). Example plots are shown for the small intestine and are gated on CD4þ lymphocytes. (g) Total
number of OT.II T-cells in the mLN at the indicated time points post infection. (h) Expression of CCR9 (WT n¼ 20, KO n¼18) and a4b7 (WT n¼ 16, KO
n¼14) by CD4þ T-cells in the mLN. (i) The dilution of carboxyfluorescein succinimidyl ester (CFSE) was used to measure proliferation of OT.II cells at
day 3 (n¼12) and day 6 (WT n¼12, KO n¼ 10) post infection in the mLNs. Graph shows percentage of cells that diluted CFSE; see Supplementary
Figure S2 for data expressed as the division index.36 (j) Activation of OT.II cells in the spleen (n¼8) and mLN (n¼ 12) was determined by staining for
CD69 and comparing with naive controls. (k) Expression of indicated transcription factors by OT.II cells in themLNwas analyzed by intracellular staining
and flow cytometry at day 3 post infection (WT n¼ 6, KO n¼8). (l) 2 106 cells frommLN suspensions at day 3 post infection were restimulated in vitro
withOVA323-339 peptide and IL-17 in the supernatantmeasured byELISA (WT n¼10, KOn¼ 6). Bar charts showpooled data (2–4 experiments); overlaid
dot plots show a single representative experiment. TCR, T-cell receptor. *Po0.05.
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Calb-Ag to test antigen-specific T-cell responses to fungi
colonizing the GI tract; however, we found that this model did
not sufficiently stimulate transferred OT.II cells (data not
shown). Instead, we therefore immunised WT and Dectin-1
KOs systemically via the tail vein with OVA and oligodeox-
ynucleotide, and analyzed responding OT.II cells in the spleen
and the GI tract. Similar to the subcutaneous immunisations
described above, the absence of Dectin-1 had no effect on the
antigen-specific CD4þ T-cell response (Figure 4d–f). These
results therefore demonstrate that the loss of Dectin-1 does not
influence T-cell immunity in response to unrelated ligands, and
that this receptor is specifically required to control CD4þ
T-cell responses in the GI tract during fungal infection.
Loss of Dectin-1 alters DC responses in the mLN
We next determined whether haematopoietic or stromal
components were involved in the Dectin-1 KO pheno-
type. For these experiments, we generated bone
marrow chimeric mice and then characterized the effects of
infection on OT.II responses in the GI tract in these
animals. We found that reconstitution of Dectin-1-deficient
mice with WT bone marrow restored the frequency
of OT.II cells in the mLN and intestinal tissue (Figure 5a).
Notably, there was a significant reduction in intestinal fungal
burdens in animals reconstituted with WT bone marrow
compared with mice reconstituted with KO bone marrow
(Figure 5b).
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Figure 3 Dectin-2 is not required for antigen-specific CD4þ T-cell responses in the GI tract. WT (filled bars/circles) and Dectin-2 KO (light
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As these results suggested that a haematopoietic component
was largely responsible for the phenotype observed in the
Dectin-1 KO animals, we next explored DC responses in the GI
tract of these mice. For these experiments, we used flow
cytometry to compare different DC sub-populations within the
mLN, based on their expression of CD103 and CD11b; an
approach that allows the identification of developmentally
and functionally distinct DC subsets22 (Figure 5c). In naive
WT animals, we found the highest expression of
Dectin-1 on migratory CD103þ DC subsets in the mLN
(Figure 5c). Following infection with C. albicans, we found a
significant reduction in the number of total DCs (CD11cþ
MHC IIþ ) and the three major DC subsets in the infected
Dectin-1 KO mLN, whereas no difference was found in
naive animals (Figure 5d, e). Thus, these data show that
absence of Dectin-1 during infection leads to abrogated DC
numbers in the mLN.
Dectin-1 is required for efficient CD4þ T-cell activation
Defects in T-cell co-stimulation have been previously shown to
result in aberrant proliferation and activation,23 thus we next
investigated the ability of Dectin-1 / DCs isolated from the
infected mLN to activate CD4þ T-cells in vitro. To analyse this
aspect of the DC response, we purified CD11cþ cells from
infected WT and Dectin-1 / mLNs and used equivalent
numbers of these cells to stimulate naive OT.II T-cells in vitro.
We found thatOT.II cells had lower levels of proliferation when
co-cultured with Dectin-1 / CD11cþ cells compared with
those cultured withWTCD11cþ cells (Supplementary Figure
S3), mimicking what we had earlier seen in vivo (Figure 1i).
Critically, when we measured production of IL-2 in the
supernatants of our OT.II co-cultures by enzyme-linked
immunosorbent assay, we found that OT.II cells co-cultured
with purifiedDectin-1 / CD11cþ cells produced significantly
less IL-2 compared with T-cells co-cultured with WT CD11cþ
cells (Figure 5f), demonstrating a defect in CD4þ T-cell
activation by Dectin-1 / DCs. To gain further insights, we
analyzed expression of co-stimulatory molecules by DCs in the
mLN following infection using flow cytometry. This analysis
revealed reductions in the expression of CD40 and OX40L,
whereas expression ofCD80, CD86, andMHCClass II remained
intact (Figure 5g). Therefore, in addition to reduced numbers,
loss of Dectin-1 expression by DCs in the mLN causes defects in
CD4þ T-cell activation.
Dectin-1 is required for CD4þ , but not CD8þ , T-cell viability
in the GI tract
As we found defects in DC number and co-stimulation we
hypothesized that this would impact on CD4þ T-cell survival,
as sufficient T-cell priming is required for initiation of pro-
survival programs.24 Attempts to analyse T-cell survival in vitro
was complicated by high background levels of apoptosis that
occurred in isolated lymphocytes, following their purification
and culture. Therefore, wemeasured the frequency of apoptotic
endogenous CD4þ T-cells in vivo using Annexin-V. In naive
mice, we observed an equivalent level of apoptotic CD4þ
T-cells in the mLNs of the WT and Dectin-1 / animals
(Figure 6a). In contrast, following infection, there was a
time-dependent increase in the frequency of apoptotic CD4þ
T-cells in the mLN of Dectin-1 / mice (Figure 6a and
Supplementary Figure S4). Adoptively transferred OT.II
cells showed similarly increased apoptosis in infected
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Figure 4 Loss of Dectin-1 does not confer global CD4þ T-cell defects. In total, 3 106 OT.II T-cells were adoptively transferred into WT (filled bars/
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Dectin-1 / mice (Supplementary Figure S5). Dectin-1
deficiency had no effect on the viability of CD8þ T-cells
(Figure 6b) or myeloid populations, including DCs, but we did
observe increased apoptosis within the B-cell population
(Supplementary Figure S5). Enhanced apoptosis in the
Dectin-1 / mLN could also be qualitatively observed
using terminal deoxynucleotidyl transferase dUTP nick end
labeling staining (Figure 6c). In addition to this increased
apoptosis, infection caused a substantial reduction in the
cellularity of the mLN in the Dectin-1 / mice over time
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n¼19, KO n¼ 16) within the mLN at 72 h post infection inWT and Dectin-1 / mice. (f) 4 104 CD11cþ cells fromWT (n¼8) and Dectin-1 / (n¼ 8)
mice were purified from the mLN at 72 h post infection and cultured with 2 105 naive OT.II T-cells and 10mgml 1 OVA323-339 peptide. IL-2 in the
supernatants was measured 24 h later and expressed relative to the WT. (g) FACS analysis of the indicated co-stimulation molecules relative to naive
controls at 72 h post infection by CD11cþMHCIIþ cells in the mLN (n¼12). Bar charts show pooled data (chimera/IL-2: two experiments; DC data: five
experiments); overlaid dot plots show one representative experiment. *Po0.05.
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(Figure 6d), which became macroscopically smaller during
infection (Figure 6e). Decreased cellularity was only
observed in the mLN and not in other tissues, such as the
renal LN (Supplementary Figure S6). The loss in cellularity
affected all cell populations (Supplementary Figure S6).
It is unclear whether this phenotype is directly related to
increased CD4þ T-cells and B-cell apoptosis, since we
did not find any significant reductions in the frequencies of
individual lymphocyte populations after infection in the
Dectin-1 / mLN (Supplementary Figure S6). Notably,
the loss in cellularity was not restricted to the mLN, as
there were also less-visible Peyer’s patches in the Dectin-1 /
small intestine (Figure 6f). These effects only occurred
during infection, as in naive animals these tissues were
equivalent to those of WT mice (Figure 6d–f). Moreover,
these defects were specific to Dectin-1, as no reduction in mLN
cellularity or number of Peyer’s patches occurred during
infection in the Dectin-2 / mice (Supplementary Figure
S7). There was also no effect on mLN cellularity when the
Dectin-1 KO animals were maintained on cholestyramine
diet (Figure 6g), supporting our previous observation
(see Figure 1c-e) that increased bile acids in the GI tract
are not responsible for the phenotype in these tissues during
infection. Thus, our data reveal a specific function for Dectin-1
in the maintenance of gut-associated lymphoid organs during
fungal infection.
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Figure 6 Dectin-1 is required for CD4þ T-cell survival. (a) The frequency of apoptotic CD4þ T-cells was measured by Annexin-V staining in mLN cell
suspensions at the indicated time points post infection (WT n¼ 9, KO n¼ 9 at each time point). (b) CD8þ T-cell apoptosis and necrosis wasmeasured by
Annexin-V/7-AAD staining in mLN cell suspensions at 72 h post infection (n¼6). (c) TUNEL staining performed on paraformaldehyde-fixed mLNs from
infectedWTandKOmice 72 hpost infection; photo taken at 5 magnification, insert at 40 magnification. Blue¼DAPI, green¼ apoptotic cells. (d) The
total number of recoverable cells from the mLN (WT n¼ 9, KO n¼ 9 at each time point). (e) H&E staining of mLNs at 72 h post infection compared with
naive controls (scale bars are 500 mm). (f) The total number of visible (41mm3)Peyer’s patches (infectedn¼ 9, naiven¼8) inWTandDectin-1 / mice
at 72 h post infection. (g) The total number of recoverable cells from the mLN of infected WT (n¼10) and KO (n¼9) mice at 3 days post infection while
maintained on cholestyramine diets, as described in Figure 1. (h) Schematic of the colitis model where co-housed WT and Dectin-1 KO animals were
maintained on water supplemented with penicillin, streptomycin, and fluconazole for 4 days, and then switched to water containing 3.5% DSS and C.
tropicalis for 5 days. The number of (i) Peyer’s patches and (j) number of DCs (CD11cþMHCIIþ ) isolated frommLNs fromWT (n¼20) and Dectin-1 KO
(n¼ 16)mice at 5 days postDSSexposurewas comparedwithCandidaonlyWTanimals (control,n¼ 6). Bar charts showpooled data (2–5 experiments);
overlaid dot plots show one representative experiment. *Po0.05.
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Dectin-1 is required for maintenance of intestinal lymphoid
tissues during colitis
Our data have shown that Dectin-1 has a crucial role in the
maintenance of GI-lymphoid tissue following systemic fungal
infection. To gain insight into the broader ramifications of these
observations, we explored the possibility that Dectin-1 functions
were similarly required during a breach of intestinal barrier
function, such as occurs during colitis.8Notably, enhanced colitis
was not found inDectin-1 KOmice in the absence of pathogenic
fungi,8 nor did Dectin-1 KO mice exhibit abnormalities in
controllingCandidawhen the intestinal barrier is intact.14 Thus,
to explore a role for Dectin-1 during disruption of the mucosal
barrier, we used a modified version of our murine model of
colitis,8 where co-housed WT and Dectin-1 / mice were
exposed toC. tropicalis andDSS simultaneously via their drinking
water for 5 days (Figure 6h). C. tropicalis was chosen for these
experiments based on recent data, which showed that this species
specifically enhanced colitis in Dectin-1 / mice.8 Exposure of
mice to DSS and C. tropicalis induced typical signs of colitis
including colon shortening, which was more pronounced in the
Dectin-1 / mice (SupplementaryFigureS8a) aswehad shown
previously.8 In addition, the Dectin-1 KO animals fed onDSS and
C. tropicalis had significant reductions in the number of Peyer’s
patches, which was not observed in WT mice (Figure 6i). In this
model, the cellularity of themLNwashighly variable, andwe could
not detect differences in the size of this tissue in the Dectin-1 KO
mice (Supplementary Figure S8b). However, we could detect
reproducible reductions in the number of DCs in the mLN
(Figure 6j), similar to what we had observed during systemic C.
albicans infection. In summary, our data demonstrate that
Dectin-1 is important for intestinal immune responses to
pathogenic fungal flora followingdisruptionof themucosalbarrier.
WTDCs restore CD4þ T-cell responses andmLNcellularity
in Dectin-1 KO mice
We next sought to understand the link between the aberrant
CD4þ T-cell response and mLN hypocellularity in the infected
Dectin-1 KOmice. The alteration in the number and function of
DCs in the mLN, and our ability to restore T-cell responses by
reconstituting Dectin-1 KO mice with WT bone marrow
(Figure 5), suggested that defective DC responses were
responsible for the observed phenotype. To test this hypo-
thesis, we injected Dectin-1 KO animals intraperitoneally with
CD11cþ cells purified from the mLN of naive WT mice, which
were either pre-loaded with OVA or left untreated. We found
this method of DC transfer allowed DCs to migrate into the
infected mLN, as we could track labeled DCs to this site post
transfer (Supplementary Figure S9a). Following DC transfer,
these animals were subsequently given OT.II cells and infected
with Calb-Ag, as before. We found that treatment with OVA-
loaded DCs significantly restored the cellularity of the mLN
(Figure 7a), compared with infected KO mice that received
unloaded WT DCs. Moreover, OVA-loaded DC-treated mice
also had an increased frequency of OT.II cells in the mLN and
the small intestine (Figure 7b). Interestingly, treatment
with OVA-loaded DCs only slightly reduced CD4þ T-cell
apoptosis in the mLN (Figure 7c and d), suggesting that there
are other contributing factors for this particular phenotype.
Importantly, we found that treatment with OVA-loaded DCs
significantly reduced fungal burdens in the small intestine
(Figure 7e). We next tested whether the defect in Dectin-1 DC
function was simply a lack of activation, by pre-stimulating
antigen-loaded Dectin-1 KO DCs with LPS prior to adoptive
transfer. However, we found that KO mice transferred with
stimulated KO DCs still had a significantly reduced number of
cells in theirmLN, compared with themLN of KOmice that had
received WT DCs stimulated in the same way (Supplementary
Figure S9b). Thus, these data show that Dectin-1þ DCs control
mLN cellularity and antigen-specific CD4þ T-cell responses in
the GI tract during systemic candidiasis.
DISCUSSION
The far-reaching influence of commensal GI microbes on
immune development and maintenance has led to intense
interest in the regulation of intestinal barrier function and
mucosal immunity. The influence of commensal fungi in theGI
tract, in particular, is only beginning to be explored. Herein, we
describe a specific role for Dectin-1 in controlling CD4þ , but
not CD8þ , T-cell responses and survival during fungal
infection in the GI tract. Moreover, we demonstrate how loss
of this receptor also results in substantial reductions in the
cellularity of the GI-associated lymphoid organs during
systemic infection and in colitis. This reduction in mLN
cellularity affected multiple cell types without altering cellular
frequency, whereas we only observed increased apoptosis in the
CD4þ T-cell and B-cell compartments. It is possible that the
increased T and B-cells apoptosis are interlinked, as B-cell
survival can require T-cell help.25 Thus, further investigation is
required to understand how loss of Dectin-1 can result in the
rapid reduction of mLN cellularity during systemic candidiasis,
and how this phenotype relates to the defects in CD4þ T-cell
responses. Finally, we show that the loss in mLN cellularity
stems from defects in the mLNDC compartment, as transfer of
Dectin-1þ DCs into KO mice restored fungal-specific CD4þ
T-cell responses andmLNcellularity during infection, although
it did not restore the effect on CD4þ T-cell apoptosis.
Our data reveal that signaling throughDectin-1 differentially
controls the ability of DCs to induce CD4þ , but not CD8þ ,
T-cell responses during infection in vivo. In the GI tract, DCs
can be grouped into three sub-populations based on their
expression of CD103 (integrin aE) and/or CD11b. CD103þ
DCs in the mLN are thought to denote cells that have migrated
from the intestine to the mLN, whereas CD11bþCD103- DCs
in the mLN are thought to be non-migratory ‘resident’ DCs.22
However, recent reports showing trafficking of intestinal
CD103- DCs to the mLN26 indicates that DC movement in
theGI tract ismore complex than previously appreciated. In the
infected mice, the loss of Dectin-1 resulted in significant
reductions in the number of both migratory CD103þ and
resident CD103 DCs in the mLN. In contrast, in naive
animals, there were no differences in these DC populations.
Moreover, DCs isolated from the mLN of infected mice had a
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poor ability to co-stimulate CD4þ T-cells in vitro, indicating
that Dectin-1 is involved in multiple complex pathways of DC
activation in the GI tract during fungal infection. As we could
not find any differences in these cell populations in naive mice,
this indicates that Dectin-1 is important for themaintenance of
DC populations during pathogenic fungal infection but is
unaffected by commensal microbes, including fungi, in the
gut.8 Indeed, these data are consistent with our previous
observation showing that Dectin-1 expression is not detected
on the luminal-facing side of the intestinal barrier,21 and that
this receptor is not involved in controlling commensal
populations of C. albicans in the GI tract.14
CD103 and CD103þ DCs are thought to have
blood-derived precursors.27,28 In line with this, we found that
reconstitution of Dectin-1-deficient mice with WT bone
marrow restored CD4þ T-cell responses and the control of
fungal growth in the GI tract. In further experiments, we show
that this restoration is specifically due to DCs, as transfer of
these cells alone was sufficient to rescue the phenotype of the
Dectin-1 KO animals during infection. These results may stem
from aberrant trafficking of the Dectin-1 KO DCs, which was
not determined in this study. Although DC subsets in the GI
tract may have a common progenitor, they have been shown to
mediate distinct functions. For example, CD103þCD11bþ
DCs were recently shown to be important drivers of Th17
immunity in the GI tract through IL-6 production,29 whereas
the specific absence of CD103þCD11b DCs had no effect on
Th17 polarization.30 In addition to independent functions, DC
subsets in the mLN also have shared functions; the expression
of gut-homing marker CCR9 on Treg cells in the mLN was
shown to be severely reduced in the absence of both these
subsets, but was intact in singly subset deficient mice.31 Thus,
our data suggest that in the GI tract, DCs require Dectin-1 to
promote downstream CD4þ T-cell responses during fungal
infection. Interestingly, although Dectin-1þ DCs could rescue
the KO animals, they were not sufficient to fully restore CD4þ
T-cell survival during infection, an observation that requires
further exploration.
Dectin-1 is required for protecting the intestinal barrier from
invading fungi, as Dectin-1-deficient mice are more susceptible
to colitis in the presence of pathogenic fungi.8 As occurred
during systemic infection, we show here that a breach in barrier
integrity in the presence of pathogenic fungi led to reductions of
DCs in the mLN. Moreover, this treatment caused significant
reductions in the number of Peyer’s patches in theDectin-1 KO
small intestine. Recruitment of DCs to the mLN are crucial for
the generation of mucosal T-cell responses,26,29–31 and
disruption of intestinal DC migration has been linked with
poor control of bacterial and parasitic infections.32,33 There-
fore, our observations reveal a novel role for Dectin-1 in
controlling fungal-mediated inflammation during colitis.8
This gut-tropic function of Dectin-1 has broad implications
for our understanding of the control of fungi in the GI tract.
Humans with a polymorphism in Dectin-1, which renders them
essentially deficient for this receptor,34 have higher GI
colonization levels of Candida compared with control patients,
increasing the risk of systemic infection following ablative
treatment for organ transplant.35 Moreover, disruption of GI
barrier integrity is thought to be a common origin of infection in
patients with systemic candidiasis.11,12 Our data reveal one of the
mechanisms in which Dectin-1 contributes to protection of the
intestinal tissues against invasion by pathogenic fungi, and how
these mechanisms are disrupted in the absence of this receptor.
In conclusion, Dectin-1 is specifically required for CD4þ
T-cell responses in the murine GI tract in response to
fungal challenge. This function of Dectin-1 has important
implications for understanding how fungi influence adaptive
immunity at this mucosal site, and the immune mechanisms
required to control these pathogens during disease.
METHODS
Mice. Eight to 12-week-old female C57BL/6, Dectin-1 / ,14
Dectin-2 / ,6 OT.I, and OT.II mice were bred and maintained in
individually ventilated cages at the Medical Research Facility at the
University of Aberdeen. Mice were co-housed for all experiments. All
experimentation conformed to the terms and conditions of United
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Figure 7 Transfer of WT DCs restores T-cell responses and mLN cellularity in Dectin-1 KOmice. CD11cþ cells from the mLN of naive WT mice were
pre-loaded with OVA or left untreated, and injected intraperitoneally into Dectin-1 KO recipients. OT.II cells were then transferred and Calb-Ag used to
infectedmice, as for previous experiments. At 72 h post infection, animals were analyzed for (a) total number cells in themLN, (b) frequency ofOT.II cells,
(c) CD4þ T-cell apoptosis and (d) necrosis, and (e) intestine fungal burdens. All data are pooled from two independent experiments; overlaid dot plots
show one representative experiment. *Po0.05.
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KingdomHomeOffice license 60/4007 for research on animals and the
University ethical committee.
OT.II adoptive transfers. CD4þ cells were negatively purified
(Miltenyi Biotech, Surrey, UK) from lymph nodes and spleens isolated
from OT.II donor mice. Purified CD4þ cells were stained with 5 mM
carboxyfluorescein succinimidyl ester (Invitrogen, Paisley, UK) and
3 106 cells were then injected intravenously into gender-matched
recipient mice.
DC adoptive transfers. CD11cþ cells were positively purified
(Miltenyi Biotech) from themLNof naiveWTmice, and resulting cells
plated out at 2.5 105ml 1 in Roswell Park Memorial Institute
(RPMI) (Invitrogen) containing GlutaMAX and 25mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid, further supplemented
with 10% fetal calf serum, penicillin (100 unitsml 1), streptomycin
(100 unitsml 1) and 50mM b-mercaptoethanol. Some cells were
further supplemented with 10 mgml 1 OVA (EndoGrade, Hyglos,
Munich, Germany). DCs were incubated at 37 1C for 18 h, washed in
1 phosphate-buffered saline and 5 105 cells injected intraper-
itoneally into Dectin-1 KO-recipient animals.
Systemic candidiasis model. Co-housed animals were injected
intravenously with 2 105 CFU of C. albicans strain Calb-Ag,19 which
was grown in yeast extract peptone medium. Fungal burdens
were determined by serial dilution on yeast extract peptone
agar supplemented with 100 mgml 1 Gentamicin and 10 mgml 1
Vancomycin and incubation at 37 1C for 24 h.
Flow cytometry. Antibodies used in this study were CD3-APC
(145-2C11), CD4-APC H7 (GK1.5), Va2-PE (B20.1), CD45.1-PerCP
Cy5.5 (A20), CD69-AlexaFluor700 (H1.2F3), CD8-APC (53.6-7),
CD11c-BV421 (HL3), MHC Class II-FITC (2G9), a4b7-APC
(DATK32), CD103-biotin (M290), CD11b-PE Cy7 (M1/70),
CD80-V450 (16-10A1), CD86-AF700 (GL1), OX40L-PE (RM134L),
CD40-PE (3/23) purchased from BD Biosciences (Oxford, UK), and
Foxp3-CF594 (MF23), GATA-3-eFluor710 (TWAJ), RORgt-APC
(B2D), T-bet-PE Cy7 (eBio4B10), CCR9-PE Cy7 (CW-1.2) purchased
from eBioscience (Hatfield, UK). Staining was performed in 1
phosphate-buffered saline supplemented with 2% fetal calf serum and
2mM sodium azide, and anti-CD16/32 (24G2). Intracellular staining
for transcription factors was performed using the Foxp3 staining kit
from eBioscience, as per manufacturer’s instructions. Samples were
acquired on the fluorescence-activated cell sorting LSR II cytometer
(BD Biosciences). FlowJo software (Tree Star, Ashland, OR) was used
for analysis.
Generation of bone marrow chimeric mice. Six to 8-week-old
recipient mice were irradiated with two 500 rad doses, rested
overnight, and prepared bonemarrow injected intravenously 24 h after
the first irradiation. Bone marrow isolated from femurs of gender-
matched donor animals was washed and resuspended in 1
phosphate-buffered saline for injection, with each recipient receiving
2 106 bone marrow cells. Chimeric status of mice was confirmed
with a blood sample 8–10 weeks following irradiations.
Quantitative PCR. RNA was isolated using TRI Reagent (Applied
Biosystems, Paisley, UK) as per manufacturer’s instructions. Synthesis
of complementary DNA was performed on 1 mg isolated RNA using
the SuperScript III First-Strand SuperMix from Invitrogen as per
manufacturer’s instructions, and subsequently used as a template in
qPCR reactions using the SYBR green master mix (Applied
Biosystems). All reactions were performed using the LightCycler480
(Roche,West Sussex, UK). The thermal cycle used contained an initial
denaturing step of 95 1C for 5min, followed by 40–50 cycles of 95 1C
for 15 s and 60 1C for 1min. Fold change in gene expression levels were
derived using the DDCt method, where DDCt¼ (Ct Infected
TargetCt Infected Housekeeping) (Ct Naı¨ve TargetCt Naive
Housekeeping). Glyceraldehyde 3-phosphate dehydrogenase was used
as the house-keeping gene in all cases. Primer sequences: glycer-
aldehyde 3-phosphate dehydrogenase: 50-CCAGGTTGTCTCCTGCG
ACTT-30 and 50-CCTGTTGCTGTAGCCGTATTCA-30. Cyp7a1:
50-AGCAACTAAACAACCTGCCAGTACTA-30 and 50-GTCCGG
ATATTCAAGGATGCA-30. Fgf15: 50-ACGGGCTGATTCGCTAC
TC-30and 50-TGTAGCCTAAACAGTCCATTTCCT-30.
Bile-acid quantification. To quantify bile acids in the murine small
intestine, contents were collected into eppendorfs, 100 ml sterile
phosphate-buffered saline added and samples vortexed thoroughly.
Intestine contents were spun down, and bile-acid quantification
performed on the supernatants using the bile-cid colorimetric assay
from diazyme as per manufacturer’s instructions.
Intestinal isolations. To isolate lymphocytes: small intestines were
opened laterally and washed out before cutting into 1–2 cm3 pieces.
Pieces were washed twice in calcium-magnesium-free solution
(25mM sodium bicarbonate, 10mM 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid, 2% fetal calf serum in 1 Hank’s Balanced
Salt Solution (HBSS)) and then incubated with dithioerythritol
solution (1mM dithioerythritol in calcium-magnesium-free with 10%
fetal bovine serum) for 30min at 37 1C with shaking. Pieces in
dithioerythritol were vortexed for 15 s and supernatants collected and
stored on ice. Pieces were then incubated with 1mM ethylenedia-
minetetraacetic acid in 1 HBSS/1% RPMI for 30min at 37 1C with
shaking, and supernatants from this incubation discarded. In total,
10,000 units of Collagenase I (Worthington) in RPMI containing 1mM
CaCl2, 1mM MgCl2, and 5% fetal bovine serum, was then added to
pieces along with five glass beads (3-mm diameter, Sigma) and
incubated for 60min at 37 1C with shaking. Supernatants were
collected and pooled with dithioerythritol supernatants, centrifuged,
and pellets resuspended in 40% Percoll and overlaid onto 70% Percoll
prior to spinning at 2,000 rpm for 20min at 20 1C. White cells were
collected at the interphase and stained for analysis by flow cytometry.
To isolate DCs: small intestines prepared as above and washed
thoroughly in 2% fetal calf serum /HBSS. Pieces were then added into
2mM ethylenediaminetetraacetic acid /HBSS and incubated, with
shaking, at 37 1C for 20min. The supernatants from this incubation
were discarded, pieces washed in HBSS, and fresh ethylenediami-
netetraacetic acid /HBSS added and incubation at 37 1Ccontinued for a
further 20min. The supernatants from this second ethylenediami-
netetraacetic acid step were discarded, and complete RPMI supple-
mented with 1mgml 1 Collagenase I (Worthington) added to the
pieces. Collagenase digestion was allowed to continue for a maximum
of 30min at 37 1C, vortexing thoroughly every 5–10min. Supernatants
from the digest were collected, passed through 40 mM filters, washed
extensively in fluorescence-activated cell sorting buffer and stained for
analysis by flow cytometry.
In vitro restimulation assays. All cells were maintained in supple-
mented RPMI (as above) in 96-well round-bottom plates. In some
experiments, 2 106 cells (per well) isolated from lymph nodes or
spleens of infected animalswere restimulatedwith5mgml 1OVA323-339
peptide (Genscript, Piscataway, NJ) for 3–5 days at 37 1C. In other
experiments, 4 104-purified CD11cþ cells (using the CD11c
microbeads fromMiltenyi) were incubated with 2 105 OT.II cells (per
well) for 24 h at 37 1C. At the end of the incubations, IL-17 or IL-2 in the
culture supernatants were analyzed by sandwich enzyme-linked
immunosorbent assay using kits from eBioscience (IL-17) and BD
Biosciences (IL-2).
Colitis model. Co-housed WT and Dectin-1 / animals were
maintained on sterile water supplemented with 2mgml 1 strepto-
mycin, 2,000Uml 1 penicillin (both Invitrogen) and 0.25mgml 1
fluconazole (Enzo, Exeter, UK) for 4 days prior to start of experiments.
C. tropicalis AM071/0287 was resuspended at 5 106 cellsml 1 in
sterile water supplementedwith streptomycin and penicillin (as above)
and 3.5% DSS (MP Biomedicals, Santa Ana, CA, 36–50 k MW) and
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animals were maintained on Candida/DSS water for 5 days. All
animals were killed 5 days post colitis induction.
Statistical analysis. Statistical tests were performed using GraphPad
Prism 5.0. Fungal burden data were analyzed using Mann–Whitney
U-tests. Other data were analyzed using student t-tests. Data were
considered statistically significant if Po0.05.
SUPPLEMENTARYMATERIAL is linked to the online version of the paper
at http://www.nature.com/mi
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